Cargando…

Initiation of ivabradine in cardiogenic shock

AIMS: Ivabradine is a selective sinus node inhibitor indicated in patients with symptomatic chronic heart failure on stable guideline‐recommended heart failure therapy including appropriate doses of beta‐blockers. The use in cardiogenic shock remains off label and has been considered a contraindicat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chiu, Michael H., Howlett, Jonathan G., Sharma, Nakul C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Short Communications
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6816060/ https://www.ncbi.nlm.nih.gov/pubmed/31332966 http://dx.doi.org/10.1002/ehf2.12499

Ejemplares similares

Rescue extracorporeal membrane oxygenation for refractory cardiogenic shock
por: Litwiński, Paweł, et al.
Publicado: (2015)

Impella CP use in patients with non‐ischaemic cardiogenic shock
por: Maniuc, Octavian, et al.
Publicado: (2019)

Sex disparities in acute kidney injury complicating acute myocardial infarction with cardiogenic shock
por: Vallabhajosyula, Saraschandra, et al.
Publicado: (2019)

New onset migraine with aura after treatment initiation with ivabradine
por: Sprenger, Till, et al.
Publicado: (2013)

Prognostic impact of angiographic findings, procedural success, and timing of percutaneous coronary intervention in cardiogenic shock
por: Sabell, Tuija, et al.
Publicado: (2020)

Development and Validation of RP-HPLC Method for the Estimation of Ivabradine Hydrochloride in Tablets
por: Seerapu, Sunitha, et al.
Publicado: (2010)

Circulating levels of microRNA 423‐5p are associated with 90 day mortality in cardiogenic shock
por: Jäntti, Toni, et al.
Publicado: (2018)

Primary Percutaneous Coronary Intervention (PPCI) in acute myocardial infarction complicated with cardiogenic shock in a newly emerging cardiac center in Nepal
por: Maskey, Arun, et al.
Publicado: (2009)

Ivabradine improves survival and attenuates cardiac remodeling in isoproterenol‐induced myocardial injury
por: Simko, Fedor, et al.
Publicado: (2020)

Hypocalcemic cardiomyopathy presenting as cardiogenic shock
por: Gupta, Pankaj, et al.
Publicado: (2011)

Cardiogenic shock as the initial manifestation of takotsubo syndrome
por: García-Arias, Mario R., et al.
Publicado: (2022)

Cardiogenic Shock
por: Vahdatpour, Cyrus, et al.
Publicado: (2019)

Cardiogenic shock /
Publicado: (2002)

Cardiogenic shock as the initial manifestation of systemic lupus erythematosus
por: Liu, Liang, et al.
Publicado: (2020)

Cardiogenic Shock: An Unusual Initial Presentation of Churg-Strauss Syndrome
por: Apirami, M., et al.
Publicado: (2018)

Effect of Cardiogenic Shock Hospital Volume on Mortality in Patients With Cardiogenic Shock
por: Shaefi, Shahzad, et al.
Publicado: (2015)

CARDIOGENIC SHOCK WITH IMIPRAMINE
por: Chaudhury, S., et al.
Publicado: (1990)

Hypothermia in cardiogenic shock
por: van der Pals, Jesper
Publicado: (2012)

Phenotyping Cardiogenic Shock
por: Zweck, Elric, et al.
Publicado: (2021)

Syndrome of Reversible Cardiogenic Shock and Left Ventricular Ballooning in Obstructive Hypertrophic Cardiomyopathy
por: Sherrid, Mark V., et al.
Publicado: (2021)

Cardiogenic shock teams and centres: a contemporary review of multidisciplinary care for cardiogenic shock
por: Moghaddam, Nima, et al.
Publicado: (2021)

The CSP (Cardiogenic Shock Prognosis) Score: A Tool for Risk Stratification of Cardiogenic Shock
por: Tien, Yu-Tzu, et al.
Publicado: (2022)

Cardiogenic shock: an experimental animal model
por: Tanamati, C, et al.
Publicado: (2005)

Multidisciplinary teams for cardiogenic shock
por: Vallabhajosyula, Saarwaani, et al.
Publicado: (2019)

Statins for Patients with Cardiogenic Shock
por: Champion, Sébastien
Publicado: (2014)

Systems of Care in Cardiogenic Shock
por: Alvarez Villela, Miguel, et al.
Publicado: (2021)

The “Right” Side of Cardiogenic Shock
por: Brailovsky, Yevgeniy, et al.
Publicado: (2020)

Cardiogenic shock: approaching the truth
por: Llaó, Isaac, et al.
Publicado: (2022)

Is There an Obesity Paradox in Cardiogenic Shock?
por: Lavie, Carl J., et al.
Publicado: (2022)

The Battle against Cardiogenic Shock
por: Rahamim, Eldad, et al.
Publicado: (2022)

Hemodynamic monitoring in cardiogenic shock
por: Hamzaoui, Olfa, et al.
Publicado: (2022)

The medical treatment of cardiogenic shock
por: Lescroart, Mickael, et al.
Publicado: (2023)

Microcirculatory dysfunction in cardiogenic shock
por: Merdji, Hamid, et al.
Publicado: (2023)

Impella Support as a Bridge to Surgery for Severe Mitral Regurgitation With Cardiogenic Shock
por: Imaoka, Shusuke, et al.
Publicado: (2021)

ECMO in cardiac arrest and cardiogenic shock
por: Napp, L. C., et al.
Publicado: (2017)

Sacubitril/Valsartanstive Heart Failure: Cardiogenic Shock
por: Rawal, H. A., et al.
Publicado: (2018)

Ivabradine in sepsis
por: Nair, Abhijit S, et al.
Publicado: (2013)

Cardiogenic Shock Due to Atrial Arrhythmia as the Initial Presentation of Transthyretin Cardiac Amyloidosis
por: Schneider, Svenja M., et al.
Publicado: (2022)

Catastrophic health care expenditure due to septic shock and dengue shock in Vietnam
por: McBride, Angela, et al.
Publicado: (2019)

Postcardiotomy VA-ECMO for refractory cardiogenic shock
por: Charlesworth, Michael, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_7e20uvsvsulfa2vptoq52sjsjc